Fig. 1 · Structure

Documents & Downloads

Pregnenolone

Cat. No. A11909 CAS 145-13-1
Pregnenolone is an endogenous steroid hormone for inhibition of M1 receptor- and M3 receptor-mediated currents with IC50 of 11.4 μM and 6.0 μM, respectively.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
progestogen Receptor

Cellular Effect

Cell Line Activity Value Description Reference
A549 ED50 8.6 μg/mL Cytotoxicity against human A549 cells by modified MTT assay [PMID: 10650100]
HT-29 ED50 0.7 μg/mL Cytotoxicity against human HT29 cells by modified MTT assay [PMID: 10650100]
KB ED50 > 50 μg/mL Cytotoxicity against human KB cells by modified MTT assay [PMID: 10650100]
P388 ED50 7.8 μg/mL Cytotoxicity against mouse P388 cells by modified MTT assay [PMID: 10650100]

In Vitro Studies

CD4+ naive Th cells were treated with Pregnenolone at 5 μM for 72 hr under Th1 or Th2 culture conditions. Pregnenolone significantly retarded cell proliferation compared with vehicle-only-treated conditions. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Pregnenolone retards proliferation in naive Th cells

Cell-based study · CD4+ naive Th cells [1]

Naive Th cells were activated for Th1 or Th2 differentiation for 72 hr in the presence or absence of pregnenolone (5 μM). The presence of pregnenolone in the in vitro Th1 or Th2 culture conditions significantly retards cell proliferation when compared with vehicle-only-treated conditions.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell proliferation profileReported result 5 μM, 72 hr: The presence of pregnenolone in the in vitro Th1 or Th2 culture conditions significantly retards cell proliferation when compared with vehicle-only-treated conditions.[1]

Literature-Reported Treatment Conditions

Treatment concentration
5 μM
Exposure duration
72 hr
Co-treatment
Other interventions in this design: anti-CD3e 1 μg/ml; anti-CD28 5 μg/ml; recombinant murine IL-12 10 ng/ml; neutralizing anti-IL-4 5 μg/ml. Compound effect isolated by the comparison: vehicle-only-treated conditions.
Reported limits
Not stated in the sentences used: route, vehicle.
Methods and source locations

Compound reported in the paper: Pregnenolone

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > De Novo Steroid-Producing Th2 Cells Are Immunosuppessors > Pregnenolone Inhibits In Vitro Th1 and Th2 Cell Proliferation (S79, S80); Experimental Procedures > Th Cell Culture (S104, S105); Figure 5 legend (S186, S187)

cell proliferation profile: cell proliferation profile; comparator: vehicle-only-treated conditions — Results > De Novo Steroid-Producing Th2 Cells Are Immunosuppessors > Pregnenolone Inhibits In Vitro Th1 and Th2 Cell Proliferation (S80); Figure 5 legend (S186, S187)

In Vivo Studies

Pregnenolone administered i.c.v. immediately after training restored memory in POMCStarKO mice. In 4d-WD mice, Pregnenolone administered intracerebroventricularly adjacent to the ARC immediately after training normalized memory in the comparison with vehicle-treated mice. In alcohol-naïve male Alcohol-preferring (P) rats, Pregnenolone at 75 mg/kg IP had no effect on TRAF6, assessed after 45 minutes. [2,3]

Pregnenolone restores memory in POMCStarKO mice

Animal study · POMCStarKO mice; n = 3–9/genotype [2]

POMCStarKO mice received Pregnenolone i.c.v. at 2μl of 5 μg/μl immediately after training. This treatment restored memory.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
discrimination indexReported result 2μl of pregnenolone (5 μg/μl) right after the training phase: this strategy was able to restore memory of POMCStarKO mice.[2]

Conditions shared by the study groups

Route
i.c.v.
Treatment course
right after the training phase; The test phase was conducted 2 hours later
Vehicle
20% of 2-hydroxypropyl beta-cyclodextrin in NaCl 0.9%
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Pregnenolone 2μl; 5 μg/μlvehicle (Veh)2μl of pregnenolone (5 μg/μl) right after the training phase: this strategy was able to restore memory of POMCStarKO mice.[2]
Pregnenolone 2μl; 5 μg/μl
Model: POMCStarKO mice; n = 3–9/genotype
Methods and source locations

Compound reported in the paper: Pregnenolone

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > POMC neuron-derived pregnenolone mediates cognitive performance likely via autocrine mechanisms (S56, S57); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368, S370); Figure 4 legend (S447)

discrimination index: discrimination index; comparator: vehicle (Veh) — Results > POMC neuron-derived pregnenolone mediates cognitive performance likely via autocrine mechanisms (S57); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368); Figure 4 legend (S447)

Pregnenolone 2μl; 5 μg/μl · Results > POMC neuron-derived pregnenolone mediates cognitive performance likely via autocrine mechanisms (S56, S57); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368, S370)

Unchanged TRAF6 in alcohol-preferring rats

Animal study · Selectively bred, but alcohol naïve Alcohol-preferring (P) rats (male, 3–4 months old; 250–550 g; n = 7–9/group) [3]

In selectively bred, alcohol-naïve male Alcohol-preferring (P) rats, Pregnenolone administered IP at 75 mg/kg had no effect on TRAF6.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
TRAF6Reported result Pregnenolone administration had no effect on TRAF6[3]

Conditions shared by the study groups

Route
IP
Treatment course
sacrificed after 45 minutes
Vehicle
45% w/v 2-hydroxypropyl-β-cyclodextrin
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Pregnenolone 75 mg/kgvehicle (45% w/v 2-hydroxypropyl-β-cyclodextrin)Pregnenolone administration had no effect on TRAF6[3]
Pregnenolone 75 mg/kg
Model: Selectively bred, but alcohol naïve Alcohol-preferring (P) rats (male, 3–4 months old; 250–550 g; n = 7–9/group)
Methods and source locations

Compound reported in the paper: Pregnenolone

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > 3α,5α-THP inhibits TLR4 signaling and TLR4 heterodimerization in the P rat VTA (S42, S45); Materials and Methods > Animals (S99, S104)

TRAF6: TRAF6; comparator: vehicle (45% w/v 2-hydroxypropyl-β-cyclodextrin) — Results > 3α,5α-THP inhibits TLR4 signaling and TLR4 heterodimerization in the P rat VTA (S45)

Pregnenolone 75 mg/kg · Results > 3α,5α-THP inhibits TLR4 signaling and TLR4 heterodimerization in the P rat VTA (S42, S45); Materials and Methods > Animals (S104)

Pregnenolone normalizes memory in western diet mice

Animal study · 4d-WD mice; n = 6–8/group [2]

4d-WD mice received Pregnenolone intracerebroventricularly adjacent to the ARC at 2μl of 5 μg/μl immediately after training. This treatment normalized memory in the comparison with vehicle-treated 4d-WD mice.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Discrimination index during the test phase of NORTReported result 4d-WD mice; 2μl of pregnenolone (5 μg/μl) right after the training phase: this strategy normalized memory.[2]

Conditions shared by the study groups

Route
intracerebroventricularly (i.c.v.) (adjacent to the ARC)
Treatment course
right after the training phase; The test phase was conducted 2 hours later
Vehicle
20% of 2-hydroxypropyl beta-cyclodextrin in NaCl 0.9%
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Pregnenolone 2μl; 5 μg/μlvehicle (Veh)4d-WD mice; 2μl of pregnenolone (5 μg/μl) right after the training phase: this strategy normalized memory.[2]
Pregnenolone 2μl; 5 μg/μl
Model: 4d-WD mice; n = 6–8/group
Methods and source locations

Compound reported in the paper: Pregnenolone

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Cognitive impairment caused by short-term obesogenic diet, in the absence of overt metabolic disturbances, is reversed by central pregnenolone administration (S19, S20); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368, S370); Figure 1 legend (S428, S434)

Discrimination index during the test phase of NORT: Discrimination index during the test phase of NORT; comparator: vehicle (Veh) — Results > Cognitive impairment caused by short-term obesogenic diet, in the absence of overt metabolic disturbances, is reversed by central pregnenolone administration (S19, S20); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368); Figure 1 legend (S434)

Pregnenolone 2μl; 5 μg/μl · Results > Cognitive impairment caused by short-term obesogenic diet, in the absence of overt metabolic disturbances, is reversed by central pregnenolone administration (S19, S20); STAR★Methods > Method details > NORT performance after i.c.v. or intra-ARC administration of pregnenolone (S368, S370)

Specifications

Manufacturer Adooq Bioscience
CAS Number 145-13-1
Formula C21H32O2
Molecular Weight 316.48
Synonyms 5-Pregnenolone; Pregnolon; Prenolon
SMILES
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 20 mg/mL (63.19 mM)
Water Insoluble
Ethanol 20 mg/mL (63.19 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Mahata B, Zhang X, Kolodziejczyk AA, et al. Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis. Cell Rep (2014). PMID: 24813893 DOI: 10.1016/j.celrep.2014.04.011 Source material
  2. [2] Ramírez S, Haddad-Tóvolli R, Radosevic M, et al. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metab (2022). PMID: 35108514 DOI: 10.1016/j.cmet.2021.12.023 Source material
  3. [3] Balan I, Beattie MC, O'Buckley TK, et al. Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain. Sci Rep (2019). PMID: 30718548 DOI: 10.1038/s41598-018-37409-6 Source material

Added to your cart

View Cart Checkout
Loading...